entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 13:04:08 - browse：3

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Intarcia’s device

hotspot

Wikipedia

WSS

What to do when lifesaving products contribute to climate change

How to pay for weight loss drugs and save Medicare

Changes to biosimilar regulatory framework must prioritize patients

What to do when lifesaving products contribute to climate change

It's been 20 years since Dolly the sheep. Where's my clone?

Second xenotransplant done with gene

hotspot

entertainment

hotspot

Supreme Court strikes down use of affirmative action

STAT Virtual Event: Putting AI to the Test

Guidelines to prevent youth baseball injuries need more muscle

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Medicare details structure of new drug price negotiation program

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Moonlake's readout produced a cash windfall. Risks remain

Senate HELP committee spars over health care workforce policies

Walensky prepares to leave CDC — and Congress — behind

With clinical trial data readouts, here's how to spot spin

leisure time

FDA panel to weigh approval of NurOwn, controversial ALS drug

Medical student insurance fails on mental health care coverage

Microbiome research is starting to find links to chronic diseases

Flagship Pioneering launches a new biotech in two countries

Biotech stock slump in 2023: awaiting the turnaround

CDC advisers recommend seasonal use of Pfizer RSV shot

hotspot

hotspot

Wikipedia

focus